A new concept of skeletal dysplasias

Turkish Journal of Pediatrics

Volumn 46, Issue 3, 2004, Pages 197-203

  Tüysüz, Beyhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Classification; Genetics; Mutation; Osteochondrodysplasia; Skeletal dysplasia

Indexed keywords

ARYLSULFATASE; CARBONATE DEHYDRATASE; CARRIER PROTEIN; CATHEPSIN K; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYSOSOME ENZYME; PARATHYROID HORMONE RECEPTOR; PERLECAN; PROTEINASE; PYROPHOSPHATE; STRUCTURAL PROTEIN; THROMBOSPONDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ACHONDROPLASIA; ACROCEPHALOSYNDACTYLY; ALBERS SCHOENBERG DISEASE; ARTICLE; BONE DENSITY; BONE DYSPLASIA; BONE MALFORMATION; BONE RADIOGRAPHY; CHONDRODYSPLASIA; CHONDRODYSPLASIA PUNCTATA; CLEIDOCRANIAL DYSPLASIA; CLINICAL EXAMINATION; CLINICAL FEATURE; COLLAGEN DISEASE; CRANIOFACIAL SYNOSTOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DYSCHONDROSTEOSIS; EPIPHYSIS DISEASE; GENE MUTATION; GENETIC ANALYSIS; GROWTH DISORDER; HEREDITY; HUMAN; HYPOCHONDROPLASIA; MACROMOLECULE; MEDICAL SPECIALIST; MUCOLIPIDOSIS; MUCOPOLYSACCHARIDOSIS; ORTHOPEDICS; OSTEOGENESIS IMPERFECTA; PATHOGENESIS; PEDIATRICIAN; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PSEUDOHYPOPARATHYROIDISM; PSYCHIATRIST; ROBINOW SYNDROME; SCHWARTZ JAMPEL SYNDROME; SHORT STATURE; SPONDYLOEPIPHYSEAL DYSPLASIA; STICKLER SYNDROME; VITAMIN D RESISTANT RICKETS;

BONE DISEASES, DEVELOPMENTAL; CHILD; COLLAGEN; HUMANS; MUTATION; OSTEOCHONDRODYSPLASIAS; RECEPTORS, FIBROBLAST GROWTH FACTOR; TRANSCRIPTION FACTORS;

EID: 4644233718     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Basset GS. The osteochondrodysplasias. In: Morrissy RT, Weinstein SL (eds). Lowell and Winter's Paediatric Orthopaedics. Philadelphia: Lippincott-Raven; 1996: 203-254.
2. Stoll C, Dott B, Roth MP, et al. Birth prevalence rates of skeletal dysplasias. Clin Genet 1989; 35: 88-92.
3. Gustavson KH, Jorulf H. Different types of chondrodysplasia in a consecutive series of newborns. Helv Paediatr Acta 1975; 30: 307-314.
4. Spranger J. International classification of osteochondrodysplasias. The International Working Group on Constitutional Diseases of Bone. Eur J Pediatr 1992; 151: 407-415.
5. Francomano CA, Ho NC. Latest developments in skeletal dysplasias. Am J Med Genet 2001; 106: 241-243.
6. Rimoin DL. Molecular defects in the chondroplasias. Am J Med Genet 1996; 63: 106-110.
7. Baitner AC, Maurer SG, Gruen MB, DiCesare PE. The genetic basis of the osteochondrodysplasias. J Ped Orthop 2000; 20: 594-605.
8. International Working Group on Constitutional Diseases of Bone. International nomenclature and classification of osteochondrodysplasias (1997). Am J Med Genet 1998; 79: 376-382.
9. International Working Group on Constitutional Diseases of Bone. International nomenclature and classification of osteochondrodysplasias (2001). Am J Med Genet 2002; 113: 65-77.
10. Superti-Furga A, Bonafe L, Rimom DL. Molecular-pathogenetic classification of genetic disorders of the skeleton. Am J Med Genet 2001; 106: 282-293.
11. Sheldon RS. Orthophaedic Basic Science. American Academia of Orthopaedic Surgery Library of Congress Cataloging-in-Publication Card, Ohio, 1994.
12. Myllyharju J, Kivirikko KI. Collagens and collagens-related diseases. Ann Med 2001; 33: 7-21.
13. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101-116.
14. Nussbaum RL, McInnes RR, Willard HF. Genetics in Medicine (Thompson & Thompson). Philadelphia: W.B. Saunders Company; 2001: 229-234.
15. Fresinger P, Stoess BH, Pontz BF, Emmrich P, Nerlich A. Type II collagenopathies: are there additional family members? Am J Med Genet 1996; 63: 137-143.
16. Unger S, Hecht JT. Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments. Am J Med Genet 2002; 106: 244-250.
17. Wallis GA, Rash B, Sykes B, et al. Mutations within the gene encoding the alpha 1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondroplasia type Schmid but not several other forms of metaphyseal chondroplasia. J Med Genet 1996; 33: 450-457.
18. Arikawa-Hirasawa E, Wilcox WR, Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development. Am J Med Genet 2002; 106: 254-257.
19. Superti-Furga A, Rossi A, Steinmann B, Gitzelmann R. A chondroplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations. Am J Med Genet 1996; 63: 144-147.
20. Hou WS, Bromme D, Zhao Y, et al. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 1999; 103: 731-738.
21. Gedeon AK, Colley A, Jamieson R, et al. Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet 1999; 22: 400-404.
22. Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, Kitoh H. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 1999; 14: 115-125.
23. Horton WA. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr 1997; 9: 437-442.
24. Schipani E, Langman CB, Parfitt AM, et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondroplasia. N Engl J Med 1996; 335: 708-714.
25. Sabbagh Y, Jones AO, Tenenhouse HS. PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Hum Mut 2000; 16: 1-6.
26. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR Consortium. Nat Genet 2000; 25-6: 345-348.
27. Hermanns PIA, Lee B. Transcriptional dysregulation in skeletal malformation syndromes. Am J Med Genet 2002; 106: 258-271.
28. Lee B, Thirunavukkarasu K, Zhou I, et al. Missence mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 1997; 16: 307-310.